Role of Short-Acting Nitroglycerin in the Management of Ischemic Heart Disease

Drug Design, Development and Therapy - New Zealand
doi 10.2147/dddt.s79116
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Advantages of Fast-Acting ADP Receptor Blockade in Ischemic Heart Disease

Arteriosclerosis, Thrombosis, and Vascular Biology
Cardiovascular MedicineCardiology
2003English

Ischemic Heart Disease.

Japanese Journal of Geriatrics
GerontologyGeriatrics
1998English

A Review of the Current Management of Acute and Chronic Heart Failure in the Context of Ischemic Heart Disease

Continuing Cardiology Education
2017English

MRI of Ischemic Heart Disease

Nippon Hoshasen Gijutsu Gakkai zasshi
Medicine
2001English

Polygraphic Studies of the Effect of Nitroglycerin in Patients With Ischaemic Heart Disease.

Heart
Cardiovascular MedicineCardiology
1973English

Apoptosis in Ischemic Heart Disease

Journal of Translational Medicine
BiochemistryMedicineGeneticsMolecular Biology
2017English

Coagulation Factors in Ischemic Heart Disease

Circulation. Genomic and precision medicine
GeneticsCardiovascular MedicineCardiology
2018English

Hemodynamic Evaluation of Ischemic Heart Disease

Japanese Heart Journal
1973English

Tissue Doppler in Ischemic Heart Disease

2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy